Annual EBITDA
-$12.28 M
+$1.96 M+13.78%
December 1, 2023
Summary
- As of February 7, 2025, PALI annual EBITDA is -$12.28 million, with the most recent change of +$1.96 million (+13.78%) on December 1, 2023.
- During the last 3 years, PALI annual EBITDA has fallen by -$2.20 million (-21.79%).
- PALI annual EBITDA is now -21.79% below its all-time high of -$10.08 million, reached on December 31, 2020.
Performance
PALI EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$3.48 M
+$597.00 K+14.64%
September 1, 2024
Summary
- As of February 7, 2025, PALI quarterly EBITDA is -$3.48 million, with the most recent change of +$597.00 thousand (+14.64%) on September 1, 2024.
- Over the past year, PALI quarterly EBITDA has dropped by -$513.00 thousand (-17.29%).
- PALI quarterly EBITDA is now -142.89% below its all-time high of $8.11 million, reached on September 30, 2021.
Performance
PALI Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$14.05 M
+$107.00 K+0.76%
September 1, 2024
Summary
- As of February 7, 2025, PALI TTM EBITDA is -$14.05 million, with the most recent change of +$107.00 thousand (+0.76%) on September 1, 2024.
- Over the past year, PALI TTM EBITDA has dropped by -$1.77 million (-14.40%).
- PALI TTM EBITDA is now -630.35% below its all-time high of $2.65 million, reached on June 30, 2022.
Performance
PALI TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
PALI EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +13.8% | -17.3% | -14.4% |
| 3 y3 years | -21.8% | +17.2% | +46.2% |
| 5 y5 years | -21.8% | -91.8% | -284.5% |
PALI EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +49.3% | -422.8% | +17.2% | -630.4% | +46.2% |
| 5 y | 5-year | -21.8% | +49.3% | -142.9% | +88.8% | -630.4% | +64.2% |
| alltime | all time | -21.8% | +49.3% | -142.9% | +88.8% | -630.4% | +64.2% |
Palisade Bio EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$3.48 M(-14.6%) | -$14.05 M(-0.8%) |
| Jun 2024 | - | -$4.08 M(+15.7%) | -$14.16 M(+5.1%) |
| Mar 2024 | - | -$3.52 M(+18.8%) | -$13.47 M(+9.7%) |
| Dec 2023 | -$12.28 M(-13.8%) | -$2.97 M(-17.3%) | -$12.28 M(-5.7%) |
| Sep 2023 | - | -$3.59 M(+5.9%) | -$13.03 M(-3.0%) |
| Jun 2023 | - | -$3.39 M(+44.8%) | -$13.43 M(+8.5%) |
| Mar 2023 | - | -$2.34 M(-37.0%) | -$12.38 M(-13.1%) |
| Dec 2022 | -$14.24 M | -$3.71 M(-6.8%) | -$14.24 M(+50.7%) |
| Sep 2022 | - | -$3.99 M(+70.5%) | -$9.45 M(-456.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2022 | - | -$2.34 M(-44.3%) | $2.65 M(-110.1%) |
| Mar 2022 | - | -$4.20 M(-489.9%) | -$26.10 M(+7.8%) |
| Dec 2021 | -$24.22 M(+140.1%) | $1.08 M(-86.7%) | -$24.22 M(-17.5%) |
| Sep 2021 | - | $8.11 M(-126.1%) | -$29.34 M(-25.3%) |
| Jun 2021 | - | -$31.09 M(+1241.2%) | -$39.27 M(+291.9%) |
| Mar 2021 | - | -$2.32 M(-42.7%) | -$10.02 M(+30.1%) |
| Dec 2020 | -$10.08 M | -$4.05 M(+123.1%) | -$7.70 M(+110.8%) |
| Sep 2020 | - | -$1.81 M(-1.4%) | -$3.65 M(+98.6%) |
| Jun 2020 | - | -$1.84 M | -$1.84 M |
FAQ
- What is Palisade Bio annual EBITDA?
- What is the all time high annual EBITDA for Palisade Bio?
- What is Palisade Bio annual EBITDA year-on-year change?
- What is Palisade Bio quarterly EBITDA?
- What is the all time high quarterly EBITDA for Palisade Bio?
- What is Palisade Bio quarterly EBITDA year-on-year change?
- What is Palisade Bio TTM EBITDA?
- What is the all time high TTM EBITDA for Palisade Bio?
- What is Palisade Bio TTM EBITDA year-on-year change?
What is Palisade Bio annual EBITDA?
The current annual EBITDA of PALI is -$12.28 M
What is the all time high annual EBITDA for Palisade Bio?
Palisade Bio all-time high annual EBITDA is -$10.08 M
What is Palisade Bio annual EBITDA year-on-year change?
Over the past year, PALI annual EBITDA has changed by +$1.96 M (+13.78%)
What is Palisade Bio quarterly EBITDA?
The current quarterly EBITDA of PALI is -$3.48 M
What is the all time high quarterly EBITDA for Palisade Bio?
Palisade Bio all-time high quarterly EBITDA is $8.11 M
What is Palisade Bio quarterly EBITDA year-on-year change?
Over the past year, PALI quarterly EBITDA has changed by -$513.00 K (-17.29%)
What is Palisade Bio TTM EBITDA?
The current TTM EBITDA of PALI is -$14.05 M
What is the all time high TTM EBITDA for Palisade Bio?
Palisade Bio all-time high TTM EBITDA is $2.65 M
What is Palisade Bio TTM EBITDA year-on-year change?
Over the past year, PALI TTM EBITDA has changed by -$1.77 M (-14.40%)